Literature DB >> 9594915

The National Cancer Data Base: ten years of growth and commitment.

E E Partridge.   

Abstract

The National Cancer Data Base (NCDB), now 10 years old, was created to provide a resource for assessing patient care and outcomes nationally and to circulate this information to the medical community. Dr. Partridge says the NCDB clearly has succeeded in fulfilling this and other goals and can be expected to continue to be an important source for evaluating patterns of cancer care in the United States.

Entities:  

Mesh：

Year:  1998        PMID： 9594915     DOI： 10.3322/canjclin.48.3.131

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  6 in total

1.  Impact of Immunotherapy after Resection of Pancreatic Cancer.

Authors:  Thuy B Tran; Vijay K Maker; Ajay V Maker
Journal:  J Am Coll Surg       Date:  2019-02-10       Impact factor: 6.113

2.  Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.

Authors:  Jim Zhong; Kirtesh Patel; Jeffrey Switchenko; Richard J Cassidy; William A Hall; Theresa Gillespie; Pretesh R Patel; David Kooby; Jerome Landry
Journal:  Cancer       Date:  2017-05-10       Impact factor: 6.860

3.  Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer.

Authors:  Jim Zhong; Jeffrey Switchenko; Madhusmita Behera; David Kooby; Shishir K Maithel; Mark W McDonald; Jolinta Y Lin; Richard J Cassidy; Bassel El-Rayes; Jerome Landry; Pretesh R Patel
Journal:  Ann Surg Oncol       Date:  2018-01-11       Impact factor: 5.344

4.  Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.

Authors:  Jim Zhong; Jeffrey Switchenko; Naresh K Jegadeesh; Richard J Cassidy; Theresa W Gillespie; Viraj Master; Peter Nieh; Mehrdad Alemozaffar; Omer Kucuk; Bradley Carthon; Christopher P Filson; Mehmet A Bilen; Ashesh B Jani
Journal:  Am J Clin Oncol       Date:  2019-01       Impact factor: 2.339

5.  Adjuvant chemotherapy and overall survival in adult medulloblastoma.

Authors:  Benjamin H Kann; Nataniel H Lester-Coll; Henry S Park; Debra N Yeboa; Jacqueline R Kelly; Joachim M Baehring; Kevin P Becker; James B Yu; Ranjit S Bindra; Kenneth B Roberts
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

6.  Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.

Authors:  James Robert Janopaul-Naylor; Jim Zhong; Yuan Liu; Chao Zhang; Adeboye O Osunkoya; Shreyas Subhash Joshi; Mehmet Asim Bilen; Bradley Carthon; Omer Kucuk; Lindsey Marie Hartsell; Joseph Shelton; Ashesh B Jani
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.